KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to $523.3 million.

  • Neogenomics' Total Liabilities fell 2887.47% to $523.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $523.3 million, marking a year-over-year decrease of 2887.47%. This contributed to the annual value of $523.3 million for FY2025, which is 2887.47% down from last year.
  • Latest data reveals that Neogenomics reported Total Liabilities of $523.3 million as of Q4 2025, which was down 2887.47% from $536.5 million recorded in Q3 2025.
  • Over the past 5 years, Neogenomics' Total Liabilities peaked at $769.1 million during Q3 2021, and registered a low of $523.3 million during Q4 2025.
  • Over the past 5 years, Neogenomics' median Total Liabilities value was $735.2 million (recorded in 2023), while the average stood at $704.3 million.
  • In the last 5 years, Neogenomics' Total Liabilities surged by 18639.42% in 2021 and then crashed by 2887.47% in 2025.
  • Neogenomics' Total Liabilities (Quarter) stood at $761.5 million in 2021, then dropped by 2.56% to $742.0 million in 2022, then fell by 0.31% to $739.7 million in 2023, then fell by 0.54% to $735.7 million in 2024, then decreased by 28.87% to $523.3 million in 2025.
  • Its Total Liabilities was $523.3 million in Q4 2025, compared to $536.5 million in Q3 2025 and $539.9 million in Q2 2025.